Department of Pharmacology, Faculty of Medicine, Universiti Kebangsaan Malaysia, 56000 Cheras, Kuala Lumpur, Malaysia.
Pharmaceutical Informatics Institute, College of Pharmaceutical Sciences, Zhejiang University, 310030 Zhejiang, Hangzhou, China.
Biomed Pharmacother. 2022 Aug;152:113265. doi: 10.1016/j.biopha.2022.113265. Epub 2022 Jun 13.
The current prevention options for postmenopausal osteoporosis are very limited. E'Jiao is a collagen-rich traditional Chinese medicine with the potential to prevent osteoporosis but more comprehensive investigations are lacking. This study aimed to investigate the skeletal protective effects of E'Jiao in a rat model of osteoporosis caused by ovariectomy. Female Sprague Dawley rats (n = 42) were randomly assigned into baseline, sham, ovariectomised (OVX) control, OVX-treated with low-dose (0.26 g/kg), medium dose (0.53 g/kg) and high dose E'Jiao (1.06 g/kg), as well as calcium carbonate (1% w/v) groups. Daily treatment through oral gavage was initiated 7 days after OVX. The rats were euthanised after eight weeks of treatment. Bone mineral density and content were measured at baseline, 1 and 2 months after treatment. Blood was collected for the measurement of bone remodelling markers. Femur and tibial bones were collected for histomorphometry and biomechanical strength analysis. Untreated OVX rats showed high bone remodelling marked by the increased bone formation and bone resorption markers, as well as increased mineralising surface/bone surface ratio. In addition, osteoclast surface and single-labelled surface were increased while mineral apposition rate was reduced in the untreated OVX rats. These changes were antagonised by E'Jiao at all doses. However, the structural, cellular and biomechanical parameters were not affected by ovariectomy and treatment. In conclusion, E'Jiao prevented high bone remodelling during oestrogen deficiency but a long-term study will be required to establish its effects on structural and biomechanical changes due to oestrogen deficiency.
目前针对绝经后骨质疏松症的预防选择非常有限。阿胶是一种富含胶原蛋白的中药,具有预防骨质疏松症的潜力,但缺乏更全面的研究。本研究旨在探讨阿胶对去卵巢诱导骨质疏松症大鼠的骨骼保护作用。42 只雌性 Sprague Dawley 大鼠随机分为基线组、假手术组、去卵巢对照组、去卵巢+低剂量阿胶组(0.26 g/kg)、去卵巢+中剂量阿胶组(0.53 g/kg)、去卵巢+高剂量阿胶组(1.06 g/kg)以及碳酸钙(1% w/v)组。去卵巢后 7 天开始每日经口灌胃给药。治疗 8 周后处死大鼠。在治疗前、治疗 1 个月和 2 个月时测量骨密度和骨含量。采集血液用于测量骨重建标志物。收集股骨和胫骨用于组织形态计量学和生物力学强度分析。未经治疗的去卵巢大鼠表现出高骨重建,表现为骨形成和骨吸收标志物增加,以及矿化表面/骨表面比增加。此外,未经治疗的去卵巢大鼠的破骨细胞表面和单标记表面增加,而矿化速率降低。阿胶在所有剂量下均可拮抗这些变化。然而,卵巢切除术和治疗对结构、细胞和生物力学参数没有影响。总之,阿胶可预防雌激素缺乏时的高骨重建,但需要进行长期研究才能确定其对雌激素缺乏引起的结构和生物力学变化的影响。